Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study
Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, Tetsushi Murakami, Tadatsugu Anno, Kota Umeda, Mizuki Izawa, Yuto Baba, Tansei Sanjo, Kazunori Shojo, Nobuyuki Tanaka, Toshikazu Takeda, Shinya Morita, Takeo Kosaka, Ryuichi Mizuno, Yuki Arita, Hirotaka Akita, Masahiro Jinzaki, Eiji Kikuchi, Mototsugu Oya
Topics & Concepts
MedicineInternal medicineOncologyRegimenChemotherapyGemcitabineHazard ratioProportional hazards modelLymph nodeCisplatinCohortUrologyConfidence intervalBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesMultiple and Secondary Primary Cancers